"A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine showed that there were no cases of cerebral venous sinus thrombosis," it said in a statement.

Europe

AstraZeneca

Johnson & Johnson

Vaccinations

Asia

Kremlin

Pfizer

Health

Vaccines

Coronavirus

Medical

Moscow, Russia

Moscow

Times of India

News18 India

The Straits Times

Russia Today

TASS

Russia says Sputnik V vaccine does not cause blood clots

The EU will get an extra 50 million COVID vaccines from Pfizer by the end of June, Ursula von der Leyen has announced.

Ursula von der Leyen

European Union

Pandemic

Brussels

Yahoo News

Reuters

Washington Times

EU to get an extra 50 million COVID vaccines by the end of June

BRUSSELS - The EU said Wednesday it would get 50 million Pfizer vaccine doses earlier than expected, as rival drugmaker AstraZeneca faced a fresh setback after Denmark banned its use over blood clot links.

Oceania

Hindustan Times 

IBTimes

Bangkok Post 

IBTimes Australia

EU to get 50 mn Pfizer doses early as Denmark scraps AZ

People who originally signed up to get the Johnson & Johnson COVID-19 vaccine at a drive-up clinic Wednesday at the Galleria at Pittsburgh Mills are now getting the Pfizer vaccine instead, and appointments are no longer needed.

Pittsburgh

CBS Local

Pittsburgh Post-Gazette

WPXI

No appointment needed: UPMC drive-up clinic now giving out Pfizer COVID-19 vaccine instead of J&J

The first study to directly compare immune reactions between Pfizer's and AstraZeneca's COVID-19 vaccines found strong and broadly similar antibody responses in over 80-year-olds after a first dose of either shot, scientists said on Wednesday.

Science

London, England

London

BBC News

The Guardian

NDTV

Elderly show similar antibody response to 1st dose of Astra, Pfizer COVID-19 shots

Johnson & Johnson vaccine pause puts some students on edge.

US & Canada

Spectrum News

KELO

gvsu.edu

Kent State University students: No regrets for vaccine

Pfizer Inc can deliver 10% more doses of its COVID-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two weeks earlier than expected, Chief Executive Officer Albert Bourla said in a tweet on Tuesday.

New York, NY

New York

CNBC

Pfizer to deliver 10% more doses to U.S. by end of May

A U.S. appeals court upheld a decision by the Federal Trade Commission that a pay-to-delay deal between two drug makers was anti-competitive.

Today

STAT

Pfizer to boost Covid-19 vaccine production for the U.S.

Pfizer

Stay current with the most up to date news on Pfizer with news from hundreds of news sources

TRENDING NOW

LATEST STORIES

TRENDING TOPICS

Get the weekly blindspot report right in your inbox and stay up to date with your bias blindspot.

EXPLORE MORE CURRENT TOPICS

Subscribe and get full access to Ground News

EXPERIENCE